Protalix BioTherapeutics (PLX) to Present New ELELYSO Data
Tweet Send to a Friend
Protalix BioTherapeutics (AMEX: PLX) announced that new clinical data on ELELYSO and oral glucocerebrosidase (GCD), or oral GCD (PRX-112), will ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
